ugalde-morphineuseincancer-2017.pdf (125.45 kB)
Morphine use in cancer care: a survey of attitudes and perceptions in general practice patients
journal contribution
posted on 2017-10-01, 00:00 authored by M Grant, Anna UgaldeAnna Ugalde, S G Mancuso, P Vafiadis, J PhilipBackground and objectives Morphine is widely prescribed for patients with cancer, although a number of attitudes have been cited as barriers to its use, including fear, addiction and associations with death. The aim of this study was to explore the nature of these beliefs, and assess the extent to which these attitudes exist in a general practice patient population that may require morphine in the future. Methods A 30-item survey was distributed through general practices in Victoria, Australia. Results Of the 379 questionnaires distributed, 290 were collected (76.5%). Participants were predominantly neutral on questions regarding the effect of morphine on the duration of life. Morphine was seen to be prescribed responsibly (73.5%), even while most perceived its potential for addiction (69.7%). Participants with experience of morphine use had more negative perceptions regarding its efficacy. Discussion Conversations regarding morphine use should include a discussion about the beliefs and experiences of the individual, many of which may reinforce the utility of morphine.
History
Journal
Australian family physicianVolume
46Issue
10Pagination
775 - 780Publisher
Royal Australian College of General PractitionersLocation
East Melbourne, Vic.Link to full text
ISSN
0300-8495Language
engPublication classification
C Journal article; C1 Refereed article in a scholarly journalCopyright notice
2017, The Royal Australian College of General PractitionersUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC